long term care is an issue that continues to tug at Congress and this country. In 1995 the federal and state governments spent $23 billion on long term care and another $21 billion for home care. And it is estimated that those in need of long-term care will grow from 7.3 million today to 10-14 million by 2020--potentially a doubling of those in need. The appropriate care for an individual should be an issue that is made by that individual and their loved ones. But we all know the truth is that in many cases it comes down to the financial realities of the family. For many people, remaining at home is their choice. It allows them to remain with their loved ones in familiar surroundings. We need to do more to assist these people and their families if this is their choice. Toward that end I am reintroducing a bill that provides a tax credit for families caring for a relative who suffers from Alzheimer's disease. When I first came to Congress 20 years ago, not a single piece of legislation devoted to Alzheimer's disease had even been introduced. We have come along way since then, as today 'Alzheimer's' is a household word. It is also the most expensive uninsured illness in America. Alzheimer's will consume more of our national wealth- approximately $1.75 trillion--than all other illnesses except cancer and heart disease.
Editor's note · Context
Discussing the challenges and financial implications of long-term care and Alzheimer's disease.
Share
More from Olympia Snowe
I rise today with an infinite appreciation for the institution of the U.S. Senate as well as a profound sense of gratitude as I prepare to conclude my 18 years in the Senate and my nearly 40 years in elective office on behalf of the people…
I rise to both support the bill we are considering today but also to discuss the implications of Russia's accession to the World Trade Organization, WTO. I was proud to be part of a unanimous vote for this measure coming out of the Finance…
Both sides have to understand it and reach accommodation. There's no other way to do it in the United States Senate.
Exactly where does that stand today and how effective has that been, because I do think it is a great approach in helping early-stage companies to get established.





